Yale study: magic mushrooms may grow connections between brain cells
A single dose of psilocybin caused increased growth in neuron-connecting dendritic spines in mice.
Pharma giant GSK embraces digital twins for vaccine development
Pharma leviathan GlaxoSmithKline is rolling out digital twins to help create “the vaccine factory of the future.”
Low doses of nitrous oxide may treat depression
A new, small study has found that low doses of nitrous oxide — laughing gas — can treat symptoms of depression.
A small dose of an ibogaine-like drug cures stress in mice
A novel drug designed like ibogaine but without the ibogaine trip or toxicity has corrected the effects of stress in mice.
Ketamine infusion: What it's like and how it works
Ketamine infusion therapy takes the anesthetic from dance floors to depression clinics. But how does the drug work, and what is it like?
MDMA for PTSD just crushed its phase 3 trial
Results from the first phase 3 trial of using MDMA for PTSD along with talk therapy found the drug to be effective.
Phase 2 trial finds psychedelic works as well as common drug
A small study has provided evidence of psilocybin for depression working as well as a popular SSRI.
Fireside Project is a support line for your bad trip
Fireside Project is a nonprofit that is providing a support line for your challenging psychedelic experiences — read: bad trip.
"Complex" and "exciting": Researchers study the use of CBD for pain
In a small study, researchers at Syracuse found that both thinking you’re getting CBD for pain and the drug increase pain tolerance.